Editor-in-Chief
Prof. Howard L. Kaufman
Director for Rush University Cancer Center, Rush University Medical Center and Associate dean for Rush medical college, Chicago, Illinois, USA. The major research interests of Prof. Kaufman include Tumor Immunology and Immunotherapy, Melanoma, cytokines, tumor vaccines, immune monitoring.

Senior Editor
Prof. John Maher
Practises as a consultant immunologist at both King's College Hospital and Barnet and Chase Farm Hospitals and is senior lecturer in immunology at King's College Hospital. His primary research interest is adoptive T-cell immunotherapy of cancer using chimeric antigen receptor (CAR) engineered T-cells.

Prof. Guillermo D. Mazzolini
Director of Gene Therapy laboratory at Austral University. Holds a position as Independent Investigator of the National Council for Scientific and Technological Research (CONICET) and associate director of the Department of Academic Development at Hospital Universitario Austral where he practices as hepatologist.